Corient Private Wealth LLC

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1948780 MIAMI, FL

Position in AUPH

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$356,251

-$18,961 QoQ

Shares Held

20,993

-17.1% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#152

of 279 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 42% Shared 0% None 58%

Healthcare · as of Jun 30, 2026

Corient Private Wealth LLC holds $250,401,460 across 107 Biotechnology names. AUPH ranks #75 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	112,098	$55,682,439
2	IONS	Ionis Pharmaceuticals Inc	196,791	$15,603,558
3	HALO	Halozyme Therapeutics, Inc.	187,447	$14,671,476
4	KRYS	Krystal Biotech, Inc.	32,580	$12,109,008
5	TECH	BIO-TECHNE Corp	122,377	$8,645,935
6	REGN	Regeneron Pharmaceuticals, Inc.	13,758	$8,578,663
7	ALNY	Alnylam Pharmaceuticals, Inc.	23,797	$7,163,610
8	CLDX	Celldex Therapeutics, Inc.	186,110	$6,925,153

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$356,251	20,993	-17.1%	Shares	Sole	2026-08-17
2026-03-31	$375,212	25,318	-7.7%	Shares	Sole	2026-05-15
2025-12-31	$437,380	27,422	-4.0%	Shares	Sole	2026-03-09
2025-09-30	$315,588	28,560	-3.4%	Shares	Sole	2025-11-14
2025-06-30	$250,373	29,560	+57.3%	Shares	Sole	2025-09-26
2025-03-31	$151,087	18,792	-5.4%	Shares	Sole	2025-05-14
2024-12-31	$178,297	19,855	-9.2%	Shares	Sole	2025-02-10
2024-09-30	$160,197	21,855	-5.4%	Shares	Sole	2024-11-12
2024-06-30	$131,929	23,105	-1.1%	Shares	Sole	2024-08-13
2024-03-31	$117,008	23,355	-4.5%	Shares	Sole	2024-05-09
2023-12-31	$219,850	24,455	-27.5%	Shares	Sole	2024-02-09
2023-09-30	$262,012	33,721	—	Shares	Sole	2023-11-03
No filing history on record for this holder in this stock.